← Return to Boehringer Ingelheim AIRTIVITY clinical trial

Discussion
scoop avatar

Boehringer Ingelheim AIRTIVITY clinical trial

MAC & Bronchiectasis | Last Active: Jul 6 7:30am | Replies (48)

Comment receiving replies
Profile picture for becleartoday @becleartoday

She frequently felt unwell and experienced multiple exacerbations each year. These recurring illnesses disrupted her ability to maintain full-time work, leading to significant anxiety.

Living alone, she often felt vulnerable and uncertain about her future. The demands of daily airway clearance and exercise routines consumed much of her limited free time.

Brensocatib changed everything. She now feels clearer, both physically and mentally, and has reclaimed valuable time in her day. Although she was eligible to retire last year, she felt well enough to continue working a bit longer—giving her the opportunity to boost her retirement savings so in addition to buying a small home she might also travel.

Jump to this post


Replies to "She frequently felt unwell and experienced multiple exacerbations each year. These recurring illnesses disrupted her ability..."

What a success story. How fabulous for her! I hope the rest of us are as fortunate as she.

Do you think this means that she was able to scale back on airway clearance? Or maybe brensocatib reduced the phlegm so clearance times were shorter? We all know that everyone is different, so we'll just have to wait and see how it works for each of us. Fingers crossed. Thanks @becleartoday for sharing such a positive report.